Nicholas Investments Partners »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Nicholas Investments Partners

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Nicholas Investments Partners from 13F filings

Historical chart of Nicholas Investments Partners investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Nicholas Investments Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Nicholas Investments Partners

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.1M 1.0M 1.08
2024-09-30 $3.2M 2.7M 1.19

More positions owned by Nicholas Investments Partners

Bwx Technologies (BWXT)
Kratos Defense & Sec Solutio Com New (KTOS)
Rush Street Interactive (RSI)
Insmed Com Par $.01 (INSM)
Embraer Sponsored Ads (ERJ)
Rev (REVG)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Ge Vernova (GEV)
Microsoft Corporation (MSFT)
Construction Partners Com Cl A (ROAD)
Mirum Pharmaceuticals (MIRM)
Piper Jaffray Companies (PIPR)
Tanger Factory Outlet Centers (SKT)
Wintrust Financial Corporation (WTFC)

View all positions for Nicholas Investments Partners

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Millennium Management
LMR Partners
Calamos Advisors
Camden Asset Management
Balyasny Asset Management
DLD Asset Management
Point72 Asset Management
Davidson Kempner Capital Management
Jpmorgan Chase & Co
Jain Global
Nuveen
Lazard Asset Management
State Street Corporation
Absolute Investment Advisers
Citadel Advisors

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1